| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 246.741 | 215.301 | 213.827 | 223.686 | 209.450 | 202.956 | 189.556 | 179.680 | 195.613 | 176.094 |
| Total Income - EUR | 249.145 | 217.233 | 214.829 | 227.698 | 209.579 | 204.310 | 189.763 | 179.697 | 197.423 | 176.733 |
| Total Expenses - EUR | 245.638 | 223.248 | 218.409 | 220.649 | 214.620 | 208.495 | 196.276 | 182.100 | 197.530 | 191.168 |
| Gross Profit/Loss - EUR | 3.507 | -6.015 | -3.580 | 7.050 | -5.041 | -4.185 | -6.512 | -2.403 | -107 | -14.435 |
| Net Profit/Loss - EUR | 2.390 | -6.015 | -3.945 | 6.445 | -5.041 | -4.185 | -6.512 | -2.403 | -107 | -14.435 |
| Employees | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 4 | 4 | 4 |
Check the financial reports for the company - Avicenna S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 54.579 | 52.010 | 49.169 | 46.343 | 43.613 | 40.881 | 38.169 | 37.269 | 35.114 | 33.301 |
| Current Assets | 198.890 | 149.053 | 139.792 | 142.140 | 126.934 | 118.429 | 106.671 | 102.634 | 109.421 | 100.264 |
| Inventories | 84.777 | 80.007 | 78.964 | 74.170 | 62.993 | 68.242 | 56.070 | 47.598 | 49.623 | 49.135 |
| Receivables | 8.001 | 4.998 | 12.554 | 18.735 | 10.622 | 13.097 | 12.613 | 13.187 | 13.807 | 7.259 |
| Cash | 17.506 | 19.364 | 26.226 | 27.590 | 32.093 | 15.107 | 16.493 | 20.287 | 24.494 | 22.493 |
| Shareholders Funds | 200.630 | 145.736 | 138.807 | 142.704 | 134.899 | 128.157 | 118.803 | 116.769 | 116.308 | 101.222 |
| Social Capital | 45 | 45 | 9.895 | 9.713 | 9.525 | 9.344 | 9.137 | 9.166 | 9.138 | 9.087 |
| Debts | 53.286 | 55.535 | 50.155 | 45.977 | 35.833 | 31.170 | 26.247 | 23.134 | 28.228 | 32.343 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Avicenna S.r.l.